GlassScriptPhysician profile
Pamela L Kerns
NPI 1235143330
$651.21
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $557 · 2022: $29.65 · 2023: $16.14 · 2024: $48.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $64.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $64.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $67.98 | 2021 | |
| Merck Sharp & Dohme LLC | $67.78 | 2021 | |
| Novartis Pharmaceuticals Corporation | $64.44 | 2023-2024 | |
| Amgen INC. | $55.40 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $53.22 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $49.36 | 2021 | |
| Epizyme, INC. | $45.77 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.50 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $27.82 | 2021 | |
| Dendreon Pharmaceuticals LLC | $26.59 | 2021 | |
| Abbvie INC. | $20.69 | 2021 | |
| Mylan Institutional INC. | $18.10 | 2021 | |
| Rigel Pharmaceuticals, INC. | $17.89 | 2021 | |
| Kite Pharma, INC. | $17.21 | 2021 | |
| Seagen INC. | $16.17 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $15.04 | 2021 | |
| Incyte Corporation | $12.99 | 2021 | |
| Blueprint Medicines Corporation | $12.46 | 2021 | |
| Acrotech Biopharma INC. | $11.97 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.08 | 2021 | |
| Genentech USA, INC. | $9.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Kerns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.